Menu
Back to User profile » Dr Cheng-Yi Wang
Papers published by Dr Cheng-Yi Wang:
The Impact of the Pay-for-Performance Program on the Outcome of COPD Patients in Taiwan After One Year
Cheng KC, Lai CC, Wang CY, Wang CM, Ho CH, Sung MI, Hsing SC, Liao KM, Ko SC
International Journal of Chronic Obstructive Pulmonary Disease 2022, 17:883-891
Published Date: 21 April 2022
Performance and Clinical Utility of Various Chronic Obstructive Pulmonary Disease Case-Finding Tools
Chen CZ, Sheu CC, Cheng SL, Wang HC, Lin MC, Hsu WH, Lee KY, Perng DW, Lin HI, Lin MS, Lin SH, Tsai JR, Wang CC, Wang CY, Yang TM, Liu CL, Wang TY, Lin CH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3405-3415
Published Date: 18 December 2021
The Effects Of Single Inhaler Triple Therapy Vs Single Inhaler Dual Therapy Or Separate Triple Therapy For The Management Of Chronic Obstructive Pulmonary Disease: A Systematic Review And Meta-Analysis Of Randomized Controlled Trials [Corrigendum]
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:155-156
Published Date: 21 January 2020
Association between vitamin D and latent tuberculosis infection in the United States: NHANES, 2011–2012
Wang CY, Hu YL, Wang YH, Chen CH, Lai CC, Huang KL
Infection and Drug Resistance 2019, 12:2251-2257
Published Date: 22 July 2019
The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials
Lai CC, Chen CH, Lin CYH, Wang CY, Wang YH
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1539-1548
Published Date: 11 July 2019
The association between COPD and outcomes of patients with advanced chronic kidney disease
Lai CC, Wu CH, Wang YH, Wang CY, Wu VC, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2899-2905
Published Date: 17 September 2018
Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
Lai CC, Wang YH, Wang CY, Wang HC, Yu CJ, Chen L
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:867-874
Published Date: 8 March 2018
Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
Huang YL, Lai CC, Wang YH, Wang CY, Wang JY, Wang HC, Yu CJ, Chen LW
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2987-2996
Published Date: 11 October 2017
Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:2477-2485
Published Date: 21 August 2017
The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients’ life quality with COPD in Taiwan (IMPACT) study
Wang CY, Lai CC, Yang WC, Lin CC, Chen L, Wang HC, Yu CJ
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2775-2783
Published Date: 8 November 2016